Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (81-90 of 706) with videos related to

Pageof 71
Sort By:
Expert Opinion on Emerging Drugs|April 12, 2015
Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary preventionMichael M Page, Gerald F Watts
Clinical and Translational Medicine|November 27, 2023
RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I studyGerald F Watts, Dick C Chan
Current Opinion in Endocrinology, Diabetes, and Obesity|September 2, 2024
Cardiometabolic risk factors in women: what's sauce for the goose is not sauce for the ganderWann Jia Loh, Gerald F Watts
Current Atherosclerosis Reports|November 20, 2024
Inhibition of the ANGPTL3/8 Complex for the Prevention and Treatment of Atherosclerotic Cardiovascular DiseaseDick C Chan, Gerald F Watts
Current Opinion in Lipidology|February 19, 2024
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?Dick C Chan, Gerald F Watts
Clinical Therapeutics|July 31, 2023
The Promise of PCSK9 and Lipoprotein(a) as Targets for Gene Silencing TherapiesDick C Chan, Gerald F Watts
Current Atherosclerosis Reports|February 26, 2025
Quo Vadis after AEGIS: New Opportunities for Therapies Targeted at Reverse Cholesterol Transport?Nick S R Lan, Gerald F Watts
The Medical Journal of Australia|February 5, 2013
Familial hypercholesterolaemia in Australia: new insights and developmentsIan R Hamilton-Craig, Gerald F Watts
Clinical Chemistry|January 8, 2021
Hypertriglyceridemia and Alzheimer Disease: Opening the Mind to New Therapeutic OpportunitiesGerald F Watts, John C L Mamo
Current Opinion in Lipidology|October 17, 2018
Writing on the wall for precision medicine in the prevention of atherosclerotic cardiovascular diseaseGerald F Watts, Eric S G Stroes
Pageof 71

Showing results (81-90 of 706) with videos related to

Sort By:
Pageof 71
Expert Opinion on Emerging Drugs|April 12, 2015
Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary preventionMichael M Page, Gerald F Watts
Clinical and Translational Medicine|November 27, 2023
RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I studyGerald F Watts, Dick C Chan
Current Opinion in Endocrinology, Diabetes, and Obesity|September 2, 2024
Cardiometabolic risk factors in women: what's sauce for the goose is not sauce for the ganderWann Jia Loh, Gerald F Watts
Current Atherosclerosis Reports|November 20, 2024
Inhibition of the ANGPTL3/8 Complex for the Prevention and Treatment of Atherosclerotic Cardiovascular DiseaseDick C Chan, Gerald F Watts
Current Opinion in Lipidology|February 19, 2024
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?Dick C Chan, Gerald F Watts
Clinical Therapeutics|July 31, 2023
The Promise of PCSK9 and Lipoprotein(a) as Targets for Gene Silencing TherapiesDick C Chan, Gerald F Watts
Current Atherosclerosis Reports|February 26, 2025
Quo Vadis after AEGIS: New Opportunities for Therapies Targeted at Reverse Cholesterol Transport?Nick S R Lan, Gerald F Watts
The Medical Journal of Australia|February 5, 2013
Familial hypercholesterolaemia in Australia: new insights and developmentsIan R Hamilton-Craig, Gerald F Watts
Clinical Chemistry|January 8, 2021
Hypertriglyceridemia and Alzheimer Disease: Opening the Mind to New Therapeutic OpportunitiesGerald F Watts, John C L Mamo
Current Opinion in Lipidology|October 17, 2018
Writing on the wall for precision medicine in the prevention of atherosclerotic cardiovascular diseaseGerald F Watts, Eric S G Stroes
Pageof 71